June 26, 2009—Roche Pharmaceuticals announced it was suspending sales of Accutane following several substantial verdicts awarded to individuals harmed by the drug. Although the company did not classify the step as a recall, it amounted to an acknowledgement that the drug was unsafe.
More than 16 million people worldwide have used Accutane, most for the treatment of acne. Roche Pharmaceuticals is facing more than one thousand lawsuits brought by people claiming injuries from Accutane. Accutane is associated with serious gastrointestinal conditions, including: |
